Currently, type 2 neurofibromatosis can be treated with a variety of medications! The main one available in China is bevacizumab, which belongs to vascular endothelial growth factor receptor inhibitors and is a biological agent. It can effectively control the growth of tumor blood vessels, thus causing poor nutritional supply to the tumor, leading to necrosis, according to the current latest research reports, the effective rate is more than 50%. However, this kind of drug is more expensive, if necessary, patients are advised to apply for government poverty subsidy or ask for help from the Red Cross! Other drugs are in the clinical trial stage or not available in China!